clofazimine has been researched along with arachidonic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, R; O'Sullivan, JF; Savage, J; Zeis, BM | 1 |
| Anderson, R; Beyers, AD; Nel, AE; Savage, JE | 1 |
| Anderson, R; Van Rensburg, CE; Van Staden, AM | 1 |
| Anderson, R; Smit, MJ | 1 |
| Anderson, R; Prinsloo, Y; van der Walt, R; van Rensburg, CE | 1 |
| Anderson, R; Bopape, MC; Cockeran, R; Fourie, PB; Matlola, NM; Steel, HC | 1 |
6 other study(ies) available for clofazimine and arachidonic acid
| Article | Year |
|---|---|
The influence of structural modifications of dihydrophenazines on arachidonic acid mobilization and superoxide generation by human neutrophils.
Topics: Arachidonic Acid; Arachidonic Acids; Chemical Phenomena; Chemistry; Clofazimine; Humans; Leukocytes, Mononuclear; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenazines; Superoxides | 1990 |
Apparent involvement of phospholipase A2, but not protein kinase C, in the pro-oxidative interactions of clofazimine with human phagocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetophenones; Arachidonic Acid; Arachidonic Acids; Clofazimine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases; Phospholipases A; Phospholipases A2; Piperazines; Protein Kinase C; Superoxides | 1988 |
The riminophenazine agents clofazimine and B669 inhibit the proliferation of cancer cell lines in vitro by phospholipase A2-mediated oxidative and nonoxidative mechanisms.
Topics: Animals; Arachidonic Acid; Bleomycin; Cell Death; Cell Division; Cisplatin; Clofazimine; Cyclooxygenase Inhibitors; Cytotoxicity, Immunologic; Growth Inhibitors; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Methotrexate; Neutrophils; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Protein Kinase C; Tumor Cells, Cultured; Vitamin E | 1993 |
Clofazimine and B669 inhibit the proliferative responses and Na+, K(+)-adenosine triphosphatase activity of human lymphocytes by a lysophospholipid-dependent mechanism.
Topics: Anti-Infective Agents; Arachidonic Acid; Cell Division; Clofazimine; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lysophospholipase; Lysophospholipids; Phospholipases A; Sodium-Potassium-Exchanging ATPase; T-Lymphocytes; Tritium; Vitamin E | 1993 |
Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669.
Topics: Adenosine Triphosphate; Adult; Arachidonic Acid; Clofazimine; Cyclosporine; Drug Synergism; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lysophosphatidylcholines; Sodium-Potassium-Exchanging ATPase | 1995 |
Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases.
Topics: Anti-Infective Agents; Arachidonic Acid; Clofazimine; Cyclohexanones; Gene Deletion; Hydrolysis; Lipoprotein Lipase; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rubidium Radioisotopes; Type C Phospholipases | 2004 |